PATENT CLAIM ANALYSIS

Application Number: 16060146
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-09
Patent Classification: ["514", "255050"]

Abstract:
The present invention discloses a five-membered heterocyclic amide WNT pathway inhibitor, which belongs to a compound that regulates the activity of a Wnt signaling pathway, and provides a method for preparing such a compound, and the use of such a compound in preparing a medicament that antagonizes the Wnt signaling pathway. The five-membered heterocyclic amide WNT pathway inhibitor provided by the invention has a remarkable anti-tumor activity based on a target-based rational drug design of, and can be used for the development of a new generation of Wnt pathway inhibitors, and has a great clinical application value and considerable market potential.

Claim (Index 10):
A method for using of the compound or a pharmaceutically acceptable salt thereof as defined in  claim 1  in the preparation of drugs for antagonizing a Wnt signalling pathway.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 94.0
- Lexical Diversity: 1.83051
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15699112', '13948038', '13132294', '12263949', '14214185']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.780065760179534
- 35 USC 102 Novelty (BERT): 0.5378790605328347
- Combined Prediction Score: 0.7558470902148641
- Mean Citation Score: 331.698596
- Max Citation Score: 350.51352
- Similarity Product: 227.3520465150261

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test